
Zetagen Therapeutics
Biopharmaceutical company dedicated to driving breakthrough innovation in the treatment of metastatic bone cancers and osteologic interventions.
Employees
Enterprise value
$38—58m
Authorizing premium user...
Biopharmaceutical company dedicated to driving breakthrough innovation in the treatment of metastatic bone cancers and osteologic interventions.